MiR-29b expression is altered in crescent formation of HSPN and accelerates Ang II-induced mesangial cell activation

Shan Cheng1, Chun-Hua Zhu2, Ai-Hua Zhang2

  • 1Department of Infectious Disease, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing, 210008, China.

Abstract

Insights

MicroRNA-29b (miR-29b) is elevated in Henoch Schönlein purpura nephritis (HSPN) with crescents. It drives mesangial cell proliferation and inflammation by inhibiting TNFAIP3 and NKRF, contributing to HSPN progression.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Immunology

Background:

  • MicroRNA-29b (miR-29b) exhibits pro-inflammatory properties by repressing TNFAIP3.
  • miR-29b promotes cell proliferation via Smad signaling pathways.
  • The role of miR-29b in Henoch Schönlein purpura nephritis (HSPN) and its mechanism in angiotensin II (Ang II)-induced human glomerular mesangial cell (HGMC) activation requires elucidation.

Purpose of the Study:

  • To investigate the role of miR-29b in HSPN.
  • To elucidate the molecular mechanism of miR-29b in Ang II-induced HGMC activation.

Main Methods:

  • miR-29b expression was assessed in 35 HSPN renal tissues.
  • HGMCs were treated with Ang II and transfected for miR-29b overexpression or inhibition.
  • Effects on cell proliferation and inflammatory mediator release were examined.

Main Results:

  • miR-29b expression was significantly higher in HSPN renal tissues with crescents.
  • miR-29b overexpression increased HGMC proliferation, inflammatory mediator release (ICAM-1, IL-1β, IL-6, IL-8), and inhibited TNFAIP3/NKRF.
  • miR-29b inhibition reversed these effects, increasing TNFAIP3/NKRF expression.

Conclusions:

  • miR-29b expression is altered in HSPN crescent formation.
  • miR-29b accelerates Ang II-induced mesangial cell proliferation and inflammatory mediator release in HSPN.